Filomena Morisco
Filomena Morisco
Professore Associato di Gastroenterologia, UniversitÓ di Napoli Federico II
Verified email at
Cited by
Cited by
Dietary antioxidant compounds and liver health
P Vitaglione, F Morisco, N Caporaso, V Fogliano
Critical reviews in food science and nutrition 44 (7-8), 575-586, 2005
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
F. 2005. Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo
G Graziani, G D’Argenio, C Tuccillo, C Loguercio, AM Ritieni
Gut 54, 193-200, 0
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 1-11, 2015
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins
P Vitaglione, F Morisco, G Mazzone, DC Amoruso, MT Ribecco, ...
Hepatology 52 (5), 1652-1661, 2010
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects
C Loguercio, V De Girolamo, I de Sio, C Tuccillo, A Ascione, F Baldi, ...
Journal of hepatology 35 (5), 568-574, 2001
Long-term outcome of interferon-α-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment
C Carella, G Mazziotti, F Morisco, G Manganella, M Rotondi, C Tuccillo, ...
The Journal of Clinical Endocrinology & Metabolism 86 (5), 1925-1929, 2001
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects
F Esposito, F Morisco, V Verde, A Ritieni, A Alezio, N Caporaso, ...
Alimentary pharmacology & therapeutics 17 (4), 595-601, 2003
Serum insulin‐like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus‐relatedá…
G Mazziotti, F Sorvillo, F Morisco, A Carbone, M Rotondi, G Stornaiuolo, ...
Cancer: Interdisciplinary International Journal of the American Cancerá…, 2002
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ...
Journal of Hepatology 61 (2), 333-341, 2014
The addition of ribavirin to interferon-a therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increasesá…
C Carella, G Mazziotti, F Morisco, M Rotondi, M Cioffi, C Tuccillo, ...
Eur J Endocrinol 146 (6), 743-749, 2002
Longitudinal study of antibodies against thyroid in patients undergoing interferon-α therapy for HCV chronic hepatitis
C Carella, G Amato, B Biondi, M Rotondi, F Morisco, C Tuccillo, ...
Hormone Research in Paediatrics 44 (3), 110-114, 1995
The impact of coffee on health
K Nieber
Planta medica 83 (16), 1256-1263, 2017
Use of N, N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma
V Verde, V Fogliano, A Ritieni, G Maiani, F Morisco, N Caporaso
Free Radical Research 36 (8), 869-873, 2002
Sustained virological response: a milestone in the treatment of chronic hepatitis C
F Morisco, R Granata, T Stroffolini, M Guarino, L Donnarumma, L Gaeta, ...
World journal of gastroenterology: WJG 19 (18), 2793, 2013
Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis
N Caporaso, M Romano, R Marmo, I De Sio, F Morisco, A Minerva, ...
Journal of hepatology 12 (3), 367-371, 1991
Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study
A Grasso, R Stigliano, F Morisco, H Martines, A Quaglia, AP Dhillon, ...
Transplantation 81 (11), 1532-1541, 2006
The system can't perform the operation now. Try again later.
Articles 1–20